Setara Biosciences
a clinical-stage rare disease biotech formed by Actio Biosciences alums
Biotechnology
Amount raised
$90M
Round
Series A
Date raised
October 30, 2026
Founded
—
CompanySetara Biosciences
IndustryBiotechnology
Founders
- David GoldsteinCo-founder, President and Executive Chair
- David BreckenridgeCo-founder and Chief Scientific Officer
Get new raises like this every week
Free weekly list of newly funded startups and their founders.
About Setara Biosciences
a clinical-stage rare disease biotech formed by Actio Biosciences alums
- How much did Setara Biosciences raise?
- Setara Biosciences raised $90M in a Series A round on October 30, 2026.
- Who founded Setara Biosciences?
- David Goldstein and David Breckenridge co-founded Setara Biosciences.